Clinical Trials Browser

Phase 1 × Completed × Triple Negative Metastatic Breast Cancer × Clear all

NCT00516724 2025-04-11

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Phase 1 Completed

BreastGynecologic

Triple Negative Metastatic Breast Cancer